跳至主要内容
临床试验/CTRI/2024/06/068864
CTRI/2024/06/068864已完成2/3 期

A Pharmaco-Therapeutic Study of Varun and Indrayava in Vatarakta w.s.r to Gout

Government Ayurvedic College and Hospital Patna Aryabhatta Knowledge University Patna Bihar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年6月24日最近更新:
适应症
相关药物

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Improvement in the patient will be assessed mainly on the basis of relief in cardinal symptoms of disease. To access the effect of drug therapy subjectively, all sign & symptoms will be relief in

研究概览

简要总结

Vatarakta is a chronic  is a chronic and complex metabolic disorder of musculoskeletal system and characterised by severe pain, tenderness, inflammation and burning sensation in the affected joints. Vatarakta is a Vatapradhana Vyadhi where Rakta is main Dushya. The drug used in this trial is Varun churna and Indrayava churna  mentioned in Ayurveda text with hope that they will prove more efficacious, less toxic and easy to use. This drug is easily available and  effective in Vatarakta. Patient will be taken from OPD and IPD of Government Ayurvedic College and Hospital Patna. Duration of trial is 30 days.

研究设计

研究类型
Interventional

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Patient willing for Trial.
  • •Patient having symptoms of Vatarakta vyadhi as per ayurvedic classic and Gout w.s.r to modern view have include under the study.
  • •Patient having age between 20-60 year who can present their sign and symptoms of Vatarakta.

排除标准

  • •Patients who have HIV HCV CKD etc Patients suffering from serious systemic disorder like Diabetes Renal Calculus Hepatic Disorder are excluded Cardiac patients Cancer patient On Chemotherapy patient On Dialysis patient are excluded Patient who have suffering from serious lungs disorders Asthmaticus Bronchogenic Carcinoma or other types of malignancy Pregnant and Lactating Women Anemia- less than hemoglobin 9mgdl.

结局指标

主要结局

Improvement in the patient will be assessed mainly on the basis of relief in cardinal symptoms of disease. To access the effect of drug therapy subjectively, all sign & symptoms will be relief in

时间窗: 60 Days (8 weeks)

1. pain in affected joint.

时间窗: 60 Days (8 weeks)

2. swelling in the affected joint.

时间窗: 60 Days (8 weeks)

3. law of tactile sensation. upon their severity.

时间窗: 60 Days (8 weeks)

次要结局

  • chaneges in serum uric acid and blood urea(60 days)

研究者

发起方
Government Ayurvedic College and Hospital Patna Aryabhatta Knowledge University Patna Bihar
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Raj Kishor Verma

Government Ayurvedic College and Hospital Patna

研究点 (1)

Loading locations...

相似试验